These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9019574)

  • 1. [Clinical evaluation of Spersallerg preparation for non-infectious conjunctivitis and infectious conjunctivitis with a hyperergic component].
    Nizankowska MH; Lukasik-Czerek A
    Klin Oczna; 1996 Jan; 98(1):41-3. PubMed ID: 9019574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epinastine 0.05% ophthalmic solution in contact lens-wearing subjects with a history of allergic conjunctivitis.
    Nichols KK; Morris S; Gaddie IB; Evans D
    Eye Contact Lens; 2009 Jan; 35(1):26-31. PubMed ID: 19125045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allergic conditions of the eye].
    Thurau S
    MMW Fortschr Med; 2004 Feb; 146(7):41-4. PubMed ID: 15347048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant papillary conjunctivitis.
    Donshik PC; Ehlers WH; Ballow M
    Immunol Allergy Clin North Am; 2008 Feb; 28(1):83-103, vi. PubMed ID: 18282547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Allergodil eye drops in the treatment of allergic conjunctivitis].
    Haicl P; Cerná H
    Cesk Slov Oftalmol; 2002 Jul; 58(4):254-8. PubMed ID: 12181881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emedastine and allergic conjunctivitis: new preparation. Poor assessment.
    Prescrire Int; 2001 Apr; 10(52):39-40. PubMed ID: 11718155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of tacrolimus, fluorometholone, and saline in mild-to-moderate contact lens-induced papillary conjunctivitis.
    Diao H; She Z; Cao D; Wang Z; Lin Z
    Adv Ther; 2012 Jul; 29(7):645-53. PubMed ID: 22821643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topical application of ibudilast for seasonal allergic conjunctivitis in patients wearing soft contact lenses.
    Sakuma K; Toshida H; Honda R; Tanaka K; Fukazawa A; Takahashi K; Suto C; Ebihara N; Murakami A
    Eye Contact Lens; 2009 Sep; 35(5):251-4. PubMed ID: 19672196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
    Abelson MB; Greiner JV
    Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant papillary conjunctivitis.
    Donshik PC
    Trans Am Ophthalmol Soc; 1994; 92():687-744. PubMed ID: 7886881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis].
    Maĭchuk IuF; Khaitova KN; Grishakova MB
    Vestn Oftalmol; 1998; 114(4):43-4. PubMed ID: 9771090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis.
    Miyake-Kashima M; Takano Y; Tanaka M; Satake Y; Kawakita T; Dogru M; Asano-Kato N; Fukagawa K; Fujishima H
    Jpn J Ophthalmol; 2004; 48(6):587-90. PubMed ID: 15592786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nedocromil sodium 2% ophthalmic solution for the treatment of ragweed pollen seasonal allergic conjunctivitis.
    Blumenthal MN; Schwartz RH; Kaiser H
    Ocul Immunol Inflamm; 2000 Sep; 8(3):159-67. PubMed ID: 11120577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the efficacy and safety of lodoxamide in patients with allergic eye diseases].
    Dekaris I; Gabrić N; Lazić R; Bosnar D; Cima I; Stipić A
    Acta Med Croatica; 2002; 56(3):93-8. PubMed ID: 12630339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Giant papillary conjunctivitis].
    Bischoff G
    Klin Monbl Augenheilkd; 2014 May; 231(5):518-21. PubMed ID: 24799171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The antiallergic eye drops "polynadyme": development, experimental and clinical studies].
    Maĭchuk IuF; Pozdniakov VI; Pozdniakova VV; Iakushina LN
    Vestn Oftalmol; 2006; 122(5):35-8. PubMed ID: 17087034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lodoxamide versus spaglumic acid: a comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by Parietaria pollen.
    Purello D'Ambrosio F; Gangemi S; Ricciardi L; Cuzzocrea S; Di Lorenzo G
    Allergol Immunopathol (Madr); 1997; 25(5):233-7. PubMed ID: 9395007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of contact lens-related complications: UCLA contact lens study.
    Forister JF; Forister EF; Yeung KK; Ye P; Chung MY; Tsui A; Weissman BA
    Eye Contact Lens; 2009 Jul; 35(4):176-80. PubMed ID: 19474751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.
    Mah FS; Rosenwasser LJ; Townsend WD; Greiner JV; Bensch G
    Curr Med Res Opin; 2007 Jun; 23(6):1445-52. PubMed ID: 17559743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cyclosporine 0.05% ophthalmic emulsion for contact lens-intolerant patients.
    Hom MM
    Eye Contact Lens; 2006 Mar; 32(2):109-11. PubMed ID: 16538135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.